For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

In the first few months of 2026, the news about advancements in cancer research including topics about targeted therapies, early detection and drug development. But to get a better idea of the “how,” ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...

New research breaks it down.

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

A cancer dietitian has shared 10 simple diet and lifestyle changes you can make to reduce your risk of cancer, from eating ...

The American Cancer Society estimates more than 20,000 Arkansans will be diagnosed with some form of cancer this year. Cancer ...